A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

Clinical trial NCT00420199 · COMPLETED

Trial details

NCT number: NCT00420199
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Active Rheumatoid Arthritis

Start date: 2007-05-01
Primary completion: 2009-08-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.